CD90+ cell populations have been isolated from both HCC specimens and blood samples of liver cancer patients and could initiate tumor nodule formation following intrahepatic injection into SCID/beige mice and subsequent secondary and tertiary transplantation into immunodeficient mice. This evidence concerns the gene THY1 and hepatocellular carcinoma.